Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease

Hepatology

Volumn 38, Issue 4, 2003, Pages 811-819

  Bienzle, Ulrich ^a,c   Günther, Matthias ^a   Neuhaus, Ruth ^a   Vandepapeliere, Pierre ^b   Vollmar, Jens ^b   Lun, Andreas ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c Institute of Tropical Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FAMCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHORYL LIPID A; PREDNISOLONE; RECOMBINANT HEPATITIS B VACCINE; TACROLIMUS; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG COST; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; INJECTION PAIN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0141532308     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50396     Document Type: Article

References (35)

1. Steinmüller T, Seehofer D, Rayes N, Müller AR, Settmacher U, Jonas S, Neuhaus R, et al. Increasing applicability of liver transplantation for patients with hepatitis B-related liver disease. HEPATOLOGY 2002;35:1528-1535.
2. Paya CV. Prevention of fungal and hepatitis virus infections in liver transplantation. Clin Infect Dis 2001;33(Suppl 1):47-52.
3. Samuel D, Alexander G. Liver transplantation for hepatitis B virus infection. Liver Transpl Surg 1995;1:270-274.
4. Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. HEPATOLOGY 1998;28:585-589.
5. Shouval D, Samuel D. Hepatitis B immune globulin to prevent hepatitis B virus graft infection following liver transplantation: a concise review. HEPATOLOGY 2000;32:1189-1195.
6. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. HEPATOLOGY 1998;27:213-222.
7. Bárcena R, Fernandez-Braso M, Urman J, Lopez-San Roman A, del Campo S, Moreno N, Lopez P, et al. Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis. Transplant Proc 1999;31:2459-2460.
8. Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, Cirera I, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. HEPATOLOGY 2000;31:496-501.
9. Sanchez-Fueyo A, Martinez-Bauer E, Rimola A. Hepatitis B vaccination after liver transplantation. HEPATOLOGY 2002;36:257-259.
10. Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, et al. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. HEPATOLOGY 2002;35:176-181.
11. Bienzle U, Günther M, Neuhaus R, Neuhaus P. Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: preliminary results. Liver Transpl 2002;8:562-564.
12. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-1108.
13. Böcher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouval D, Löhr HF, et al. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with the failure to produce antigen-specific antibodies in the trimera mouse. HEPATOLOGY 2000;31:480-487.
14. Höhler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, Vollmar J, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002;360:991-995.
15. Yoshida EM. Hepatitis B infection and liver transplantation. Can J Gastroenterol 1997;11:462-468.
16. Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl 2002;8:2-9.
17. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;355: 561-565.
18. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunizations in solid-organ transplant recipients. Lancet 2002;359:957-965.
19. Loinaz C, de Juanes JR, Gonzales EM, Lopez A, Lumbreras C, Gomez R, Gonzales-Pinto I, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44:235-238.
20. Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel ML. Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg. J Med Virol 1993;39:67-74.
21. Akbar SMF, Kurosa K, Tanimoto K, Masumoto M, Michitaka K, Horiike N, Onji M. Vaccine therapy for hepatitis B virus (HBV)-carriers: a study in murine HBV-carriers on dose, duration and prognosis [Abstract]. HEPATOLOGY 1995;22:224A.
22. Pol S, Driss F, Michel ML, Nalpas B, Berthelot P, Brechot C. Specific vaccine therapy in chronic hepatitis B infection. Lancet 1994;344:342.
23. Michel ML, Pol S, Brechot C, Tiollais P. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future. Vaccine 2001;19: 2395-2399.
24. Pol S, Nalpas B, Driss F, Michel ML, Tiolais P, Denis J, Bréchot C, and a multicenter study group. Efficacy and limitations of a specific immunotherapy in a chronic hepatitis B. J Hepatol 2001;34:917-921.
25. Dahmen A, Herzog-Hauff S, Böcher WO, Galle PR, Löhr HF. Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B. J Med Virol 2002;66:452-460.
26. Senturk H, Tabak F, Akdogan M, Erdem L, Mert A, Ozaras R, Sander E, et al. Therapeutic vaccination in chronic hepatitis B. J Gastroenterol Hepatol 2002;17:72-76.
27. Burbach GJ, Bienzle U, Neuhaus R, Hopf U, Metzger WG, Pratschke J, Neuhaus P. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997;63:478-480.
28. Adler R, Safadi R, Caraco Y, Rowe M, Etzioni A, Ashur Y, Shouval D. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation. HEPATOLOGY 1999;29:1299-1305.
29. Leroux-Roels G, Desombere I, Koutsoukos M, Janssens M, Wettendorf M, Vandepapeliere P. Characterisation of H BV envelope-specific humoral and cellular immune responses induced by vaccination of healthy adult volunteers [Abstract]. Antiviral Ther 2000;5(Suppl 1):41.
30. Ambrosch F, Wiedermann G, Kundi M, Leroux-Roels G, Desombere I, Garcon N, Thiriart C, et al. A hepatitis B vaccine formulated with a novel adjuvant system. Vaccine 2000;18:2095-2101.
31. O'Hagen D, MacKichan ML, Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 2001;18:69-85.
32. Raz E, Michaeli J, Brezis M, Popovizer MM, Gazitt Y, Shouval D. Improvement of immune complex nephritis associated with hepatitis B surface antigen excess. Am J Nephrol 1989;9:162-166.
33. Celis E, Abraham KG, Miller RW. Modulation of the immunological response to hepatitis B virus by antibodies. HEPATOLOGY 1987;7:563-568.
34. Wen YM, Qu D, Zhou SH. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B. Int Rev Immunol 1999;18:251-258.
35. Lok AS. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 2002;8:67-73.